Granahan Investment Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-527,147
| Closed | -$6.94M | – | 182 |
|
2024
Q4 | $6.94M | Sell |
527,147
-211,105
| -29% | -$2.78M | 0.29% | 88 |
|
2024
Q3 | $8.28M | Sell |
738,252
-243,797
| -25% | -$2.73M | 0.33% | 93 |
|
2024
Q2 | $10.6M | Sell |
982,049
-64,796
| -6% | -$697K | 0.42% | 77 |
|
2024
Q1 | $15.6M | Sell |
1,046,845
-103,921
| -9% | -$1.55M | 0.55% | 59 |
|
2023
Q4 | $20.8M | Buy |
1,150,766
+211,557
| +23% | +$3.83M | 0.69% | 45 |
|
2023
Q3 | $16.3M | Buy |
939,209
+128,852
| +16% | +$2.23M | 0.58% | 51 |
|
2023
Q2 | $14.7M | Buy |
810,357
+291,392
| +56% | +$5.28M | 0.45% | 65 |
|
2023
Q1 | $13.8M | Buy |
518,965
+13,781
| +3% | +$367K | 0.42% | 71 |
|
2022
Q4 | $9.77M | Buy |
505,184
+124,091
| +33% | +$2.4M | 0.3% | 93 |
|
2022
Q3 | $7.96M | Sell |
381,093
-148,718
| -28% | -$3.11M | 0.26% | 102 |
|
2022
Q2 | $4.24M | Buy |
529,811
+40,477
| +8% | +$324K | 0.14% | 127 |
|
2022
Q1 | $3.43M | Buy |
489,334
+216,149
| +79% | +$1.52M | 0.09% | 151 |
|
2021
Q4 | $3.69M | Buy |
+273,185
| New | +$3.69M | 0.08% | 163 |
|